Ghent University Academic Bibliography

Your filters: cql: author="Houdayer, Claude" or (type any "bookEditor issueEditor" and editor="Houdayer, Claude")

Add to list
- Journal Article
- A2
- open access
Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS) : a European cohort study

Linda A. J. Hendricks, Katja C. J. Verbeek, Janneke H. M. Schuurs-Hoeijmakers, Robin de Putter (UGent) , Hilde Brems, Sien H. Van Daele, Violetta C. Anastasiadou, Lenka Foretová, Patrick R. Benusiglio, Anna Gerasimenko, et al.

(2025) BJC REPORTS. 3(1).
Add to list
- Journal Article
- A1
- open access
The risk of a second primary cancer in PTEN Hamartoma Tumor Syndrome (PHTS)

Linda A.J. Hendricks, Katja C.J. Verbeek, Janneke H.M. Schuurs-Hoeijmakers, Mirjam M. de Jong, Thera P. Links, Hilde Brems, Mio Aerden, Joan Brunet, Roser Lleuger-Pujol, Robert Hüneburg, et al.

(2025) GENETICS IN MEDICINE. 27(10).
Add to list
- Conference Paper
- C3
Cancer prognosis in PTEN Hamartoma Tumor Syndrome : a European cohort study

Linda Hendricks, Katja Verbeek, Hilde Brems, Robin de Putter (UGent) , Lenka Foretova, Chrystelle Colas, Patrick Benusiglio, Claude Houdayer, Arne Jahn, Verena Steinke-Lange, et al.

(2024) EUROPEAN JOURNAL OF HUMAN GENETICS. In European Journal of Human Genetics 32(Supplement 1). p.563-564
Add to list
MYT1L-associated neurodevelopmental disorder : description of 40 new cases and literature review of clinical and molecular aspects

Juliette Coursimault, Anne-Marie Guerrot, Michelle M. Morrow, Catherine Schramm, Francisca Millan Zamora, Anita Shanmugham, Shuxi Liu, Fanggeng Zou, Frederic Bilan, Gwenael Le Guyader, et al.

(2022) HUMAN GENETICS. 141(1). p.65-80
Add to list
Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families

Xin Yang, Goska Leslie, Alicja Doroszuk, Sandra Schneider, Jamie Allen, Brennan Decker, Alison M. Dunning, James Redman, James Scarth, Inga Plaskocinska, et al.

(2020) Journal of Clinical Oncology. 38(7). p.674-687
Add to list
Comparison of mRNA splicing assay protocols across multiple laboratories: recommendations for best practice in standardized clinical testing

Phillip J Whiley, Miguel de la Hoya, Mads Thomassen, Alexandra Becker, Rita Brandão, Inge Sokilde Pedersen, Marco Montagna, Mireia Menéndez, Francisco Quiles, Sara Gutiérrez-Enríquez, et al.

(2014) CLINICAL CHEMISTRY. 60(2). p.341-352
Add to list
- Journal Article
- A1
- open access
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

Fergus J Couch, Xianshu Wang, Lesley McGuffog, Andrew Lee, Curtis Olswold, Karoline B Kuchenbaecker, Penny Soucy, Zachary Fredericksen, Daniel Barrowdale, Joe Dennis, et al.

(2013) PLOS GENETICS. 9(3).
Add to list
Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers

XianShu Wang, V Shane Pankratz, Zachary Fredericksen, Robert Tarrell, Mary Karaus, Lesley McGuffog, Paul D Pharaoh, Bruce A Ponder, Alison M Dunning, Susan Peock, et al.

(2010) HUMAN MOLECULAR GENETICS. 19(14). p.2886-2897

Academic Bibliography

Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS) : a European cohort study

The risk of a second primary cancer in PTEN Hamartoma Tumor Syndrome (PHTS)

Cancer prognosis in PTEN Hamartoma Tumor Syndrome : a European cohort study

MYT1L-associated neurodevelopmental disorder : description of 40 new cases and literature review of clinical and molecular aspects

Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families

Comparison of mRNA splicing assay protocols across multiple laboratories: recommendations for best practice in standardized clinical testing

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers

Contents

Support

Contact